Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase EARLY_PHASE1 2Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Adenocarcinoma Of Esophagus 2Melanoma 1Laryngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

YF 476 2Specimen Handling 2Aspirin 2obeticholic acid 1Ursodeoxycholic Acid 1Sunitinib 1Spectrum Analysis 1Radiofrequency Ablation 1Proflavine 1Photochemotherapy 1Metformin 1Itraconazole 1Gastroscopy 1Esomeprazole 1Endoscopy, Digestive System 1Endoscopy 1Endoscopic Mucosal Resection 1Dihematoporphyrin Ether 1Dexlansoprazole 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Barrett Esophagus × Endoscopy × Clear all
NCT06732388 2026-05-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡